title: Cytomegalovirus viremia, pneumonitis, and tocilizumab therapy.
authors.forename: David
authors.initials: D
authors.lastname: van Duin
authors.forename: Cyndee
authors.initials: C
authors.lastname: Miranda
authors.forename: Elaine
authors.initials: E
authors.lastname: Husni
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000502:physiology*; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy / Q000821:virology; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011014:Pneumonia / Q000150:complications / Q000188:drug therapy; D016896:Treatment Outcome; D014766:Viremia / Q000188:drug therapy / Q000821:virology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; C502936:tocilizumab; D015774:Ganciclovir